Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study

Autor: Sugisaka, Jun, Fujimoto, Daichi, Tamiya, Motohiro, Hata, Akito, Matsumoto, Hirotaka, Yokoyama, Toshihide, Taniguchi, Yoshihiko, Uchida, Junji, Sato, Yuki, Kijima, Takashi, Tanaka, Hisashi, Furuya, Naoki, Masuda, Takeshi, Sakata, Yoshihiko, Miyauchi, Eisaku, Saito, Go, Miura, Satoru, Yamaguchi, Teppei, Daga, Haruko, Sakata, Shinya, Yamamoto, Nobuyuki, Akamatsu, Hiroaki

Publikováno v: In Lung Cancer January 2025 199

Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic

Autor: Unagami, Kohei, Ishida, Hideki, Omoto, Kazuya, Kasahara, Mureo, Uchida, Hajime, Sakamoto, Seisuke, Futamura, Kenta, Nishikawa, Kenta, Imamura, Ryoichi, Nakazawa, Shigeaki, Hatano, Etsuro, Ito, Takashi, Masano, Yuki, Nishihira, Morikuni, Hirata, Yuta, Sakuma, Yasunaru, Onishi, Yasuharu, Yokoyama, Naoki, Yamamoto, Shingo, Yamada, Yusuke, Ogura, Yasuhiro, Kurata, Nobuhiko, Uchida, Junji, Kabei, Kazuya, Iwamoto, Hitoshi, Ikeda, Chie, Shinoda, Kazunobu, Yoshiike, Miki, Hotta, Kiyohiko, Hidaka, Yuji, Iwami, Daiki, Ishii, Yasuo, Kamiyama, Manabu, Yoshizumi, Tomoharu, Kosai-Fujimoto, Yukiko, Kobayashi, Takaaki, Motoyama, Kentaro, Yamamoto, Megumi, Asai, Toshihiro, Tasaki, Masayuki, Kenmochi, Takashi, Ito, Taihei, Tokodai, Kazuaki, Fujio, Atsushi, Tsukamoto, Yasumasa, Watanabe, Takuya, Akamatsu, Nobuhisa, Yamashina, Sachi, Ishii, Daisuke, Kitajima, Kazuki, Yamada, Yasutoshi, Mitsuke, Akihiko, Sakaguchi, Takashi, Nakamura, Michio, Tomita, Yusuke, Nakamura, Yuki, Ishimoto, Tatsuro, Ohdan, Hideki, Tanimine, Naoki, Fujiwara, Takuzo, Yanagihara, Mitsuki, Hatakeyama, Shingo, Takai, Manabu, Nose, Kazuhiro, Kikuchi, Takashi, Mori, Yasunori, Araki, Motoo, Sekito, Takanori, Nishimura, Shingo, Tanabe, Tatsu, Igarashi, Yuto, Hidaka, Sumi, Watanabe, Masaaki, Ariyoshi, Yuichi, Hasegawa, Yasushi, Kamiyama, Masato, Yoneda, Tatsuo, Shimizu, Tomokazu, Nishikawa, Kouhei, Fukumoto, Takumi, Kuramitsu, Kaoru, Kato, Masashi, Saito, Mitsuru, Shinkai, Makoto, Usui, Hidehito, Sato, Masaaki, Eguchi, Hidetoshi, Imamura, Hiroki, Kobayashi, Shogo, Soejima, Yuji, Mita, Atsuyoshi, Kobayashi, Takashi, Nakamura, Kenji, Ohtsuka, Masayuki, Nakada, Shinichiro, Yagi, Takahito, Yasui, Kazuya, Matsuno, Naoto, Mizuno, Chiharu, Sugimoto, Mikio, Ueda, Nobufumi, Okada, Yoshinori, Hirama, Takashi, Toyooka, Shinichi, Sugimoto, Seiichiro, Matsubara, Kei, Ikegami, Toru, Furukawa, Kenei, Nitta, Hiroyuki, Katagiri, Hirokatsu, Onita, Toru, Shiraishi, Takeshi, Mizuno, Shugo, Amiya, Eisuke, Shintani, Yasushi, Kanou, Takashi, Funaki, Soichiro, Miura, Yoshifumi, Nakajima, Daisuke, Urahashi, Taizen, Matsumiya, Goro, Watanabe, Michiko, Ebisu, Yosuke, Osawa, Ryosuke, Ono, Minoru, Sogawa, Hiroshi, Gomi, Harumi, Chen-Yoshikawa, Toyofumi, Yoshida, Kazunari, Ogawa, Naoko, Yamanaga, Shigeyoshi, Shimata, Keita, Ohfuji, Satoko, Yoshikawa, Mikiko, Natori, Yoichiro, Hibi, Taizo, Yuzawa, Kenji, Egawa, Hiroto

Publikováno v: In American Journal of Transplantation August 2024 24(8):1495-1508

Daprodustat for Post-Transplant Anemia in Renal Transplant Recipients

Autor: Machida, Yuichi, Iwai, Tomoaki, Kabei, Kazuya, Naganuma, Toshihide, Uchida, Junji

Publikováno v: In Transplantation Proceedings April 2024 56(3):534-539

Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer

Autor: Minami Seigo, Kijima Takashi, Shiroyama Takayuki, Okafuji Kohei, Hirashima Tomonori, Uchida Junji, Imamura Fumio, Osaki Tadashi, Nakatani Takeshi, Ogata Yoshitaka, Yamamoto Suguru, Namba Yoshinobu, Otsuka Tomoyuki, Tachibana Isao, Komuta Kiyoshi, Kawase Ichiro

Publikováno v: BMC Research Notes, Vol 6, Iss 1, p 3 (2013)

Abstract Background In recent years, maintenance chemotherapy is increasingly being recognized as a new treatment strategy to improve the outcome of advanced non-small cell lung cancer (NSCLC). However, the optimal maintenance strategy is still contr

Externí odkaz: https://doaj.org/article/71182083284945f3858ffe491f65f0f8

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.